By the Top Tier Newswire AI Desk · August 5, 2026 at 10:24 AM ET · reviewed against 9 wire stories
HINGE HEALTH INC A (HNGE) is up +9.85% in the latest session. Our newswire has captured 9 stories on HNGE across 6 sources in the last 36 hours, with AI sentiment reading bullish (avg 62/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
HNGE stock rose 9.85% to $87.24 on Monday, driven by a combination of strong earnings results, an acquisition announcement, and upgraded analyst price targets. The company reported record Q2 2026 results, raised its full-year revenue guidance, and announced a $105 million acquisition of Cylinder Health to expand into gastrointestinal care. Analysts from Stifel, Citizens, and Needham raised their price targets following the developments.
What Happened
Hinge Health reported Q2 2026 results that outperformed expectations, with revenue growth and a raised 2026 guidance of $856 million to $860 million. The company also announced the acquisition of Cylinder Health, a provider of digital GI care with over 150,000 patients treated. The deal, expected to close in Q3 2026, is a strategic move into a high-growth healthcare niche. The acquisition was cited as a key factor in Stifel and Citizens raising their price targets to $96 and $97 respectively, while Evercore ISI Group and Barclays also increased their targets to $105 and $100. These analyst actions, combined with the earnings beat and guidance raise, fueled investor optimism.
What The Data Shows
The stock opened with a -1.9% gap from the prior close and traded in a volatile session, reaching a high of $87.94 before closing near that level. The intraday volume of 1.1 million shares was 0.7 times the 3-month average. Over the past eight sessions, the stock had gained 8.2%, rising from $74.31 to $80.37. Meanwhile, insider transactions over the last 90 days totaled $288.2 million in sales, with no insider purchases recorded. The stock currently trades within its 52-week range of $30.08 to $91.50, near the upper end.
What To Watch
The company’s Q2 2026 earnings call transcript and 8-K filing provide further details on its financial performance and strategic direction. Investors should monitor the closing of the Cylinder Health acquisition in Q3 2026 and the company’s progress toward its 2026 revenue target. Analyst coverage remains strong, with multiple firms having raised price targets in recent days.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
HNGE · Aug 5 session (5-min) · +2.05% vs prior close · updated 8:57 PM ETAI sentiment, last 36h · averaged over 9 stories · 62/100 bullish
The headlines behind the move
Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
5d agoMarketChameleonBULLISH 63M&A
Hinge Health Makes $105 Million Move Into GI Care With Cylinder Health Acquisition—What Does This Mean for the Future of Integrated Digital Healthcare?
August 5, 2026
Hinge Health is expanding its digital healthcare reach with a $105 million acquisition of Cylinder Health, targeting the underserved gastrointestinal (GI) market. This strategic move is set to launch a unified GI care program by 2027, combining digital MSK, migraine, and GI care within a single platform. Here’s what this could mean for patients, employers, and the broader digital health landscape.
Citizens raises Hinge Health stock price target on GI expansion, results
Citizens raises Hinge Health stock price target on GI expansion, results
5d agoSeeking AlphaBULLISH 73Earnings
Hinge Health forecasts $856M-$860M 2026 revenue as it plans broader GI rollout in 2027
Hinge Health (HNGE) Q2 2026 earnings call: revenue beat, raised 2026 guidance, Cylinder Health acquisition, and GI/migraine growth—read key takeaways.
5d agoSeeking AlphaNEUTRAL 50Earnings
Hinge Health, Inc. (HNGE) Q2 2026 Earnings Call Transcript
Hinge Health, Inc. (HNGE) Q2 2026 Earnings Call August 4, 2026 4:30 PM EDTCompany ParticipantsBianca Buck - Finance & Head of Investor RelationsDaniel...
6d agoTipRanksBULLISH 73Earnings
Hinge Health Posts Record Q2 Results, Raises Outlook
An update from Hinge Health, Inc. Class A ( ($HNGE) ) is now available. Hinge Health, Inc. is a San Francisco-based digital health company focused on scaling and au...
6d agoSEC 8-KNEUTRAL 50General
Hinge Health, Inc. (HNGE) files 8-K
Filed: 2026-08-04 AccNo: 0001628280-26-052558 Size: 642 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
6d agoStockTitanBULLISH 62M&A
Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care
Cylinder has treated over 150,000 people and serves nearly 100 clients across two million lives; the acquisition is expected to close in Q3 2026.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →